Combined Prednisone and Mycophenolate Mofetil Treatment for Retroperitoneal Fibrosis
- 4 January 2011
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 154 (1) , 31-36
Abstract
Small case series suggest that a combination of mycophenolate mofetil and prednisone may be an effective treatment for patients with retroperitoneal fibrosis. To describe the outcomes of adults with retroperitoneal fibrosis who received a combination of prednisone and mycophenolate mofetil. Prospective case series of patients followed between 1 April 2005 and 1 July 2009. Single tertiary care facility. 28 patients with retroperitoneal fibrosis. Prednisone, 40 mg/d, tapered over 6 months, and mycophenolate mofetil, 1000 mg twice daily, for a mean of 24.3 months. Clinical course, laboratory assessment, and measurement of periaortic mass. Mean follow-up was 1012 days, and no patients were lost to follow-up. Systemic symptoms resolved in all patients; 89% had a 25% or greater reduction in periaortic mass. Elevated erythrocyte sedimentation rate and serum creatinine level and decreased hemoglobin level normalized in all patients. Disease recurred in 2 of 28 patients. This was a small case series. Combined prednisone and mycophenolate mofetil therapy is a potentially effective treatment for retroperitoneal fibrosis that warrants evaluation in randomized trials. None.Keywords
This publication has 23 references indexed in Scilit:
- Mycophenolate mofetil in the treatment of retroperitoneal fibrosisClinical Rheumatology, 2008
- Combined Prednisone and Mycophenolate Mofetil Treatment for Retroperitoneal FibrosisJournal of Urology, 2007
- Long-Term Renal and Patient Outcome in Idiopathic Retroperitoneal Fibrosis Treated With PrednisoneAmerican Journal of Kidney Diseases, 2007
- Retroperitoneal fibrosisThe Lancet, 2006
- Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 casesThe American Journal of Medicine, 2004
- Equivalent Pharmacokinetics of Mycophenolate Mofetil in African-American and Caucasian Male and Female Stable Renal Allograft RecipientsAmerican Journal of Transplantation, 2003
- Mycophenolate mofetil: new applications for this immunosuppressantAnnals of Allergy, Asthma & Immunology, 2003
- Steroid Therapy For Idiopathic Retroperitoneal Fibrosis: Dose And DurationJournal of Urology, 2002
- Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosisClinical Rheumatology, 1995
- Treatment of Idiopathic Retroperitoneal Fibrosis by ImmunosuppressionJournal of Urology, 1991